Synthetic Biology Market Forecast Report to 2029: Focus on Market Opportunities: Use of Machine Learning in Synthetic Biology and Growing Demand for Fuel Alternatives

Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) — The “Synthetic Biology: Global Markets” report has been added to ResearchAndMarkets.com is a software research and development company. offering.

The global synthetic biology market was valued at $15.4 billion in 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 26.1% to reach $61.6 billion by the end of 2029.

Several factors make the synthetic biology industry a prime candidate for growth. First, there are many synthetic biology applications with sizable potential markets and a slow penetration rate; as these rates increase, the industry will grow rapidly. Second, innovation in the industry is being driven by the creation of exciting new technologies. These technologies include new gene editing platforms, enzymatic DNA synthesis, and ultra-high-throughput screening platforms for organism engineering. Third, the industry is emphasizing value-added products rather than price-sensitive commodities.

Today, synthetic biology foundries regularly create, build, and test designer organisms that can generate cost-effective end products. The process involves changing the genomes of these organisms to create the ideal combination of taste and texture for the food industry. In the textile industry, designer organisms help achieve the ideal balance of weight, dimensional variability, strength, flexibility, and specific surface and structural modification. These types of high-value synthetic biology end products are expected to drive significant market expansion in this industry.

Scope of the report

  • The scope of the study includes synthetic biology core products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media), and enabling technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are projected to be commercialized through 2029.
  • Key synthetic biology technologies and products are analyzed to determine the current and future status of the market as well as the projected growth from 2024 to 2029. An in-depth analysis of strategic alliances, industry structures, competitive dynamics, patents, and market driving forces is also provided.
  • The report examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.
  • By geographic region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW).

The report includes

  • 50 data tables and 45 additional tables
  • An analysis of global markets for synthetic biology products and technologies
  • Global market trends analysis, with market revenue data from 2021 to 2023, estimates for 2024 and projected CAGR to 2029
  • Estimates of current market size and revenue prospects, along with an analysis of market share by product type, end-user industry, and region.
  • Facts and figures on market drivers and challenges, innovations, technologies, industry regulations and the influence of macroeconomic factors.
  • Identification of synthetic biology core products, key enabling technologies, business opportunities for product development and competitive strategies
  • Overview of sustainability trends and ESG developments, with a focus on consumer attitudes, the ESG practices of leading companies and their ESG scores
  • An analysis of patents granted for synthetic biology, liquid biopsy and sequencing, and gene editing technologies
  • Analysis of industry structure, including company market shares, strategic alliances, mergers and acquisitions activity, and venture financing prospects.
  • Profiles of market leaders including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc. and Thermo Fisher Scientific Inc.

Key attributes:

Report attribute Details
Number of pages 137
Forecast period 2024 – 2029
Estimated market value (USD) in 2024 $19.3 billion
Market value forecast (USD) by 2029 $61.6 billion
Compound annual growth rate 26.1%
Regions covered Global

Key topics covered:

Chapter 1: Executive Summary

Chapter 2: Market Overview

  • Value chain analysis
  • Regulatory framework
  • Regulation of GEMs in the United States
  • Impacts of synthetic biology on biodiversity conservation
  • Direct impacts
  • Indirect impacts

Chapter 3: Market dynamics

  • Market drivers
    • Various applications of synthetic biology in various fields
    • Increase funding for research and development
    • The cost of DNA sequencing is falling
    • Continuous innovations in the field of synthetic biology
  • Market restrictions
    • Biosecurity, bioprotection and ethical issues
  • Market opportunities
    • Growing demand for fuel alternatives
    • Using machine learning in synthetic biology

Chapter 4: Emerging Trends and Patent Analysis

  • Emerging trends
  • CRISPR-CAS systems
  • Genetic drivers
  • Extended genetic code
  • Optogenetics
  • Synthetic genomics
  • Cell-free system
  • Microbiome engineering
  • Patent Analysis
  • Select patent grants
  • Patent Review

Chapter 5: Market Segmentation Analysis

  • Market analysis by product type
    • Enabled Products
    • Enabling Products
    • Biological components
    • Integrated systems
  • Market analysis by end user
  • Product enabled, by end user
  • End-user product enablement
  • Biological components, by end user
  • Integrated systems, by end user
  • Market analysis by region

Chapter 6: Competitive Intelligence

  • Analysis of the company’s shares
  • Investment in industry

Chapter 7: Sustainability in the synthetic biology market: ESG perspective

  • ESG trends in the biotechnology industry
  • ESG risks and challenges
  • ESG Perspective

Profiled Companies

  • Agilent Technologies
  • Amyris
  • Codex
  • Eurofins Scientific
  • Genscript
  • Biological works of Ginkgo
  • Merck Pharmaceutical Company
  • Fisher Scientific Thermo
  • Bioscience Twist
  • Virids

For more information about this report, please visit https://www.researchandmarkets.com/r/lcxz1j

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We bring you the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

  • Global synthetic biology market


            

#Synthetic #Biology #Market #Forecast #Report #Focus #Market #Opportunities #Machine #Learning #Synthetic #Biology #Growing #Demand #Fuel #Alternatives

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top